Main content

Robert E. Sobol Lymphokine Gene Therapy Collection

Notifications

Held at: Science History Institute Archives [Contact Us]315 Chestnut Street, Philadelphia, PA 19106

This is a finding aid. It is a description of archival material held at the Science History Institute Archives. Unless otherwise noted, the materials described below are physically available in their reading room, and not digitally available through the web.

Overview and metadata sections

Call Number:
033
Repository:
Science History Institute Archives
Extent:
0.2 linear feet (1 half-hollinger box.)
Language:
English
Preferred Citation:
Item Description, Box Number, Folder Number, Robert E. Sobol Lymphokine Gene Therapy Collection, 1991-1995, Science History Institute Archives, Philadelphia, Pennsylvania.
Date:
1991-1995 (inclusive)
Creator:
Geneditor Biologics Corporation and Sobol, Robert E., 1952-
Form:
Archival materials
Abstract:
A collection of proposals, applications, and articles from 1991 to 1995 pertaining to lymphokine gene therapy research and the study of tumor immunotherapy collected and maintained by Robert E. Sobol.

Arranged alphabetically by subject, the Robert E. Sobol Lymphokine Gene Therapy Collection includes a collection of documents collected and maintained by Robert E. Sobol, Chairman and Chief Executive Officer of Geneditor Biologics Corporation, from 1991 to 1995. The collection includes a proposal to the Office of Recombinant DNA Activities of the National Institutes of Health (NIH) and Department of Health and Human Services New Drug Applications, in addition to other associated materials pertaining to lymphokine gene therapy research and the study of tumor immunotherapy.

The Robert E. Sobol Lymphokine Gene Therapy Collection was donated to the Science History Institute by Robert E. Sobol in June 2023.

There are no other known archival collections created by Robert E. Sobol preserved at the date of processing.

Organization
Subject

Publisher
Science History Institute Archives
Finding Aid Author
Finding aid created and encoded into EAD by Sean Cureton.
Finding Aid Date
2023
Access Restrictions

There are no access restrictions on the materials for research purposes and the collection is open to the public.

Use Restrictions

The Science History Institute holds copyright to the Robert E. Sobol Lymphokine Gene Therapy Collection. The researcher assumes full responsibility for all copyright, property, and libel laws as they apply.

Collection Inventory

"Cancer Patient Gets Unproven Therapy," Los Angeles Times, Article, 1993 January 6.
Box 1 Folder 1
Department of Health and Human Services New Drug Application for "Tumor and Fibroblasts Genetically Modified to Secrete Interleukin-2", 1992 November 19.
Box 1 Folder 2
Printout of Paper Abstract, "Interleukin-2 Gene Therapy in Patient with Glioblastoma", 1995 March 2.
Box 1 Folder 3
Program Summary, Cytokine Gene Therapy of Cancer with Transduced Fibroblasts, 1992 September 23.
Box 1 Folder 4
Proposal to the Office of Recombinant DNA Activities of the National Institutes of Health (NIH), "Lymphokine Gene Therapy of Cancer: Phase I Study of Tumor Immunotherapy with Autologous Fibroblasts Genetically Modified to Secrete Interleukin-2", 1991 October 24.
Box 1 Folder 5
Revised New Drug Application for the Department of Health and Human Services for "Tumor and Fibroblasts Genetically Modified to Secrete Interleukin-2", 1992 December 10.
Box 1 Folder 6
Revised New Drug Application for the Department of Health and Human Services for "Tumor and Fibroblasts Genetically Modified to Secrete Interleukin-2", 1993 January 4.
Box 1 Folder 7
Timeline of Key Events and Documents, First Human Immune Gene Therapy, 1995 March 1.
Box 1 Folder 8

Print, Suggest